ZMUni Compliance Centre

ZMUni Compliance Centre

Menu
ZMUni Compliance Centre

News

>

Industry Insights

Increasing Regulatory Scrutiny of Cross-Border Health Supplements in China
Published on:2026-11-20

In recent months, China's General Administration of Customs (GACC) has issued a series of safety alerts concerning health supplements sold through cross-border e-commerce channels. The products involved cover a range of categories, including weight-management supplements, men's health products, botanical formulations, beauty supplements and general nutritional products.

 

image.png

 

Some alerts followed GACC's own risk monitoring of cross-border e-commerce imports, while others relayed safety concerns reported by overseas regulators, including Australia's Therapeutic Goods Administration (TGA) and the US Food and Drug Administration (FDA).

 

The reported concerns include undeclared pharmaceutical ingredients, substances not permitted for use in food, contaminants, heavy metals and potential adverse reactions.

 

 

Key Products and Safety Concerns

 

Recent alerts have covered several categories of health supplements, with reported safety concerns varying by product type:

 

  • Weight-management supplements: Undeclared pharmaceutical ingredients and substances not permitted for use in food.

  • Men's health and prostate support products: Undeclared pharmaceutical ingredients and other prohibited substances.

  • Botanical and nutritional supplements: Contaminants in products containing ingredients such as quercetin and oyster-derived compounds, as well as potential severe allergic reactions associated with andrographis-containing products.

  • Beauty and general wellness supplements: Excessive lead levels and the presence of substances not permitted for use in food.

 

These alerts were based on different sources of information. Some followed GACC's own risk monitoring of cross-border e-commerce imports, while others reflected safety concerns reported by overseas regulators, including Australia's Therapeutic Goods Administration (TGA) and the US Food and Drug Administration (FDA).

 

 

What Do These Alerts Mean for International Brands?

 

China's health food registration and filing procedures for general-trade imports can be time-consuming, particularly for products subject to registration. As a result, some overseas brands turn to cross-border e-commerce as an alternative route to reach Chinese consumers.

 

Under China's cross-border e-commerce retail import framework, eligible products imported for personal use are generally exempt from certain first-import registration, filing and licensing requirements that apply to general-trade imports. This provides a more flexible route to the Chinese market, but does not mean that products can enter China without regard to their safety.

 

Recent safety alerts issued by GACC and overseas regulators highlight concerns such as undeclared pharmaceutical ingredients, prohibited substances, contaminants and excessive heavy metal levels in certain supplements sold through cross-border e-commerce channels. These cases serve as a reminder that, even where general-trade market access requirements do not apply, overseas brands remain responsible for ensuring the basic safety and quality of their products.

 

 

* This article is for informational purposes only and does not constitute legal or regulatory advice.

This article is original content from ZMUni Compliance Center. Please contact us for reprinting.